Walleye Trading
RAPT

Walleye Trading’s RAPT Therapeutics RAPT Stock Holding History

Walleye Trading’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,577
Closed -$250K – 5296
2022
Q4 		$250K Buy
+1,577
New +$252K ﹤0.01% 3399
2021
Q4 		– Sell
-410
Closed -$102K – 5775
2021
Q3 		$102K Buy
+410
New +$108K ﹤0.01% 4354

Other funds holding RAPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Walleye Trading's RAPT Position: Q1 2023 in Review

Walleye Trading sold out of RAPT Therapeutics (RAPT) in Q1 2023, closing a stake of 1,577 shares — an estimated $250K sold.

Walleye Trading first reported a position in RAPT in Q3 2021 and held it in 2 quarters. The position peaked at $250K in Q4 2022. 106 funds tracked by Wall St. Rank hold RAPT as of Q1 2023.

  • Walleye Trading reported no remaining RAPT Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Walleye Trading sold 1,577 RAPT Therapeutics shares in Q1 2023, an estimated $250K.
  • Walleye Trading first reported a position in RAPT Therapeutics in Q3 2021 and held it in 2 quarters.
  • Walleye Trading's RAPT Therapeutics position peaked at $250K in Q4 2022.
  • 106 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2023.

Based on Walleye Trading's 13F filing for Q1 2023, filed 15 May 2023.